ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

URGN UroGen Pharma Ltd

14.15
0.33 (2.39%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 16.17M13.56M16.6M16.1M18.09M17.19M21.14M20.85M
Operating Income -19.92M-21.96M-18.72M-18.09M-20.28M-22.05M-15.38M-13.5M
Pre Tax Income -27.32M-28.07M-26.66M-25.12M-28.18M-30.19M-24.08M-21.89M
Net Income -28.45M-28.39M-26.69M-25.83M-28.87M-30.21M-24.14M-21.88M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -19.92M-21.96M-18.62M-18.05M-20.35M-22.06M-15.41M-13.47M
EBITDA -19.7M-21.74M-18.48M-17.85M-20.05M-21.83M-15.17M-13.31M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 17.53M8.16M1.13M18k11.8M48.04M64.36M82.71M
Operating Income 798k-19.95M-77.18M-109.48M-126.74M-92.29M-79.04M-65.54M
Pre Tax Income -1.94M-19.98M-75.53M-105.15M-125.11M-109.37M-108.03M-98.32M
Net Income -1.94M-20M-75.66M-105.15M-128.48M-110.82M-109.78M-102.24M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.259-1.056-3.534-4.01-4.696-4.007-3.876-2.835
EBIT 798k-19.95M-77.3M-109.76M-126.74M-92.29M-78.97M-64.7M
EBITDA 1.01M-19.74M-76.76M-109.18M-126.32M-91.46M-78.12M-64.73M

Your Recent History

Delayed Upgrade Clock